Global Increase in Demand for Monoclonal Antibodies will creates an opportunities for in Cell Line Development Market
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast
(firmenpresse) - The global cell line development market is segmented on the basis of products, sources, types of cell lines, applications, and geographies. Based on products, the global market is categorized into equipment and media and reagents. The media and reagents segment is further divided into serum, media, and reagents.
The cell line development market, by type of cell lines is segmented into primary cell lines, continuous cell lines, hybridomas, and recombinant cell lines. On the basis of source, the market is segmented into mammalians, insects, and amphibians. On the basis of applications, the market is segmented into bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery
Factors such as increasing demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies propel the growth of the market. Some of the opportunities for the market are low income countries like India and Africa lacking access to basic healthcare and increasing risk of pandemic and communicable diseases. However, in spite of innovative technologies in the market, developing stable and authentic cell lines remains a major challenge of this market.
Get More Information:https://www.marketsandmarkets.com/Market-Reports/cell-line-development-market-152900899.html
Some of the major players in the global cell line development market include American Type Culture Collection (ATCC) (U.S.), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Sigma-Aldrich Corporation (U.S.), Selexis SA (Switzerland), European Collection of Cell Cultures (ECACC) (U.K.), Corning, Inc. (U.S.), WuXi AppTec, Inc. (China), and Sartorious AG (Germany).
Contact:
Mr. Shelly Singh
MarketsandMarkets
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter(at)marketsandmarkets.com
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter(at)marketsandmarkets.com
Datum: 10.09.2018 - 10:22 Uhr
Sprache: Deutsch
News-ID 1540949
Anzahl Zeichen: 2597
contact information:
Contact person:
Town:
Phone: +44-800-368-9399
Kategorie:
Healthcare & Medical
Typ of Press Release: Erfolgsprojekt
type of sending: Veröffentlichung
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 623 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Increase in Demand for Monoclonal Antibodies will creates an opportunities for in Cell Line Development Market
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
